martes, 26 de marzo de 2013

Promoting safe prescribing in primary ca... [Ann Fam Med. 2012 Nov-Dec] - PubMed - NCBI

Promoting safe prescribing in primary ca... [Ann Fam Med. 2012 Nov-Dec] - PubMed - NCBI


Ann Fam Med. 2012 Nov-Dec;10(6):516-22. doi: 10.1370/afm.1404.


Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial.





Source


Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA. schwarzeb@upmc.edu



Abstract




PURPOSE:


Routine assessment of women's pregnancy intentions and contraceptive use-a so-called contraceptive vital sign-may help primary care physicians identify patients who need preconception or contraceptive counseling and be of particular benefit when teratogenic medications are prescribed.


METHODS:


We conducted a cluster-randomized controlled trial to evaluate the effect of a contraceptive vital sign on primary care documentation of contraceptive use and change in primary care physicians' provision of family planning services. Academic internists in the intervention group (n = 26) were provided with information on their female patients' pregnancy intentions and contraceptive use immediately before visits; internists in the control group (n = 27) received only standard intake information. Data were abstracted from the electronic health record for 5,371 visits by 2,304 women aged 18 to 50 years.


RESULTS:


Documentation of contraception increased from baseline, from 23% to 57% in the intervention group, but remained 28% in the control group, a change of +77.4 (95% confidence interval [CI], 70.7 to 84.1) adjusted percentage points in the former vs +3.1 (95% CI, 1.2 to 5.0) in the latter (P <.001). For visits involving a teratogenic prescription, documentation increased from 14% to 48% in the intervention group and decreased from 29% to 26% in the control group, a change of +61.5 (95% CI, 35.8 to 87.1) adjusted percentage points in the former vs -0.3 (95% CI, -4.3 to 3.6) in the latter (P <.001). Provision of new family planning services increased only minimally with this intervention, however. When women with documented nonuse of contraception were prescribed potential teratogens, only 7% were provided family planning services.


CONCLUSIONS:


A contraceptive vital sign improves documentation of contraceptive use; however, ongoing efforts are needed to improve provision of preconception and contraceptive services.





PMID:

23149528
[PubMed - indexed for MEDLINE]


PMCID:

PMC3495925
[Available on 2013/5/1]

Free full text

No hay comentarios: